In it, the company alarmingly advertises compounded versions of GLP-1 medicines without mentioning that these are not FDA-approved
(Source: ASMBS, June 2025) A 2026 network meta-analysis of randomized controlled trials (30 trials, 20,015 patients) found metabolic/bariatric surgery achieved significantly greater reductions than GLP-1 receptor agonists in total weight loss (10.3 percentage points), BMI (4.5 kg/m), body weight (11.7 kg), waist circumference (12.6 cm), and HbA1c (0.5%) at under 104 weeks
(2023d, May 24)
Advanced Handling Storage optimisation: Use desiccants, log temperatures, avoid fluctuations
Reduces the expression of cyclooxygenase-2 (COX-2)
H., Lu, S., Zhao, S., Cui, Y